Depression Study In Elderly Patients

• Status: Completed
• Trial end date: 2005-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Major Depressive Disorder (MDD) Study in Elderly Outpatients

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Paroxetine

Criteria

Inclusion Criteria:

• Diagnosis of Major Depressive Disorder (MDD).

• Current major depressive episode at screen at least 2 months duration.

• Must be at least 60 years of age.

Exclusion Criteria:

• Patients with a primary diagnosis other than MDD.

• Patients with a history of schizophrenia, schizoaffective disorder, bipolar disorder or dementia.

• Patients with a history of brief depressive episodes lasting less than 8 weeks.

• Patients receiving formal psychotherapy within 12 weeks of study.

• Patients who are suicidal.

• Patients who have received electroconvulsive therapy or transcranial magnetic stimulation within 6 months prior to screening.

• Patients with a history or seizure disorders.